Literature DB >> 27650274

IL-4 and human skin mast cells revisited: reinforcement of a pro-allergic phenotype upon prolonged exposure.

Magda Babina1, Sven Guhl2, Metin Artuc2, Torsten Zuberbier2.   

Abstract

Mast cells (MCs), unique cellular elements of the body, are commonly associated with IgE-mediated reactions and manifestations of Th2-type immunity. A key characteristic of the lineage is its heterogeneity, with subsets displaying significant variation depending on maturation stage, species, tissue, microenvironment and other. Heterogeneity also affects MC responses to extracellular cues. Indeed, IL-4, the signature cytokine of Th2-immunity, can affect MCs in opposing ways ranging from the induction of apoptosis to positive regulation of lineage characteristics. It is unknown, however, whether IL-4 alters the phenotype of terminally differentiated human cutaneous MCs. Using our well-established technique for homogeneous purification of human skin MCs, we now report that prolonged contact with IL-4 not only increases MC expansion, but also phenotypically and functionally re-shapes the cells. FcεRI cell surface expression, FcεRIα-specific mRNA and FcεRI-mediated histamine release are all augmented by IL-4, while histamine release elicited by the non-immunological stimulus, substance P, remains unaffected. IL-4's potential to mold MCs is broad and similarly detectable across donors. Intriguingly, IL-4 impacts granule-associated mediators, especially histamine whose synthesis is boosted in the presence of IL-4. To our knowledge, an increase in histamine production by IL-4 has not been described yet for any type of MCs, but may well contribute to its pro-allergic effect given the significance of this biogenic amine to allergic symptoms. Collectively, IL-4 alters human skin MCs after long-term exposure mimicking chronic disorders by strengthening MC numbers and intensifying processes associated with allergic inflammation.

Entities:  

Keywords:  Dermis; FcεRI; Histamine; IL-4; Mast cells; Th2

Mesh:

Substances:

Year:  2016        PMID: 27650274     DOI: 10.1007/s00403-016-1688-x

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  7 in total

1.  Interleukin 33 and interleukin 4 regulate interleukin 31 gene expression and secretion from human laboratory of allergic diseases 2 mast cells stimulated by substance P and/or immunoglobulin E.

Authors:  Anastasia I Petra; Irene Tsilioni; Alexandra Taracanova; Alexandra Katsarou-Katsari; Theoharis C Theoharides
Journal:  Allergy Asthma Proc       Date:  2018-03-01       Impact factor: 2.587

Review 2.  The Role of Crosstalk of Immune Cells in Pathogenesis of Chronic Spontaneous Urticaria.

Authors:  Bingjing Zhou; Jie Li; Runqiu Liu; Lei Zhu; Cong Peng
Journal:  Front Immunol       Date:  2022-05-31       Impact factor: 8.786

Review 3.  Mast Cells in the Skin: Defenders of Integrity or Offenders in Inflammation?

Authors:  Martin Voss; Johanna Kotrba; Evelyn Gaffal; Konstantinos Katsoulis-Dimitriou; Anne Dudeck
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

4.  Apoptotic resistance of human skin mast cells is mediated by Mcl-1.

Authors:  Tarek Hazzan; Jürgen Eberle; Margitta Worm; Magda Babina
Journal:  Cell Death Discov       Date:  2017-08-21

5.  Retinoic Acid Negatively Impacts Proliferation and MCTC Specific Attributes of Human Skin Derived Mast Cells, but Reinforces Allergic Stimulability.

Authors:  Magda Babina; Metin Artuc; Sven Guhl; Torsten Zuberbier
Journal:  Int J Mol Sci       Date:  2017-02-28       Impact factor: 5.923

6.  Cholinergic Urticaria, an Effective and Safe "Off Label" Use of Dupilumab: A Case Report with Literature Review.

Authors:  Maria Maddalena Sirufo; Alessandra Catalogna; Martina Raggiunti; Francesca De Pietro; Lia Ginaldi; Massimo De Martinis
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-02-18

7.  MRGPRX2 Is the Codeine Receptor of Human Skin Mast Cells: Desensitization through β-Arrestin and Lack of Correlation with the FcεRI Pathway.

Authors:  Magda Babina; Zhao Wang; Saptarshi Roy; Sven Guhl; Kristin Franke; Metin Artuc; Hydar Ali; Torsten Zuberbier
Journal:  J Invest Dermatol       Date:  2020-10-13       Impact factor: 8.551

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.